These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25805823)

  • 1. Reply to Jefferys: Declining HIV virulence.
    Payne R; Muenchhoff M; Goulder PJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2119. PubMed ID: 25805823
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for HIV weakening over time.
    Jefferys RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2118. PubMed ID: 25805824
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.
    Payne R; Muenchhoff M; Mann J; Roberts HE; Matthews P; Adland E; Hempenstall A; Huang KH; Brockman M; Brumme Z; Sinclair M; Miura T; Frater J; Essex M; Shapiro R; Walker BD; Ndung'u T; McLean AR; Carlson JM; Goulder PJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5393-400. PubMed ID: 25453107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host genetics and HIV--removing the mask.
    Michael NL
    Nat Med; 2002 Aug; 8(8):783-5. PubMed ID: 12152029
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved understanding of human genetic control of HIV pathogenicity.
    Griffiths PD
    Rev Med Virol; 2005; 15(1):1-2. PubMed ID: 15602704
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection].
    Boulet S; Bernard NF
    Med Sci (Paris); 2008 Dec; 24(12):1030-2. PubMed ID: 19116110
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV evolutionary dynamics within and among hosts.
    Lemey P; Rambaut A; Pybus OG
    AIDS Rev; 2006; 8(3):125-40. PubMed ID: 17078483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for abacavir hypersensitivity.
    Deresinski S
    AIDS Alert; 2007 Dec; 22(12):140-1. PubMed ID: 18411482
    [No Abstract]   [Full Text] [Related]  

  • 10. Global Database-Driven Assessment of HIV-1 Adaptation to the Immune Repertoires of Human Populations.
    Karakas A; Brumme ZL; Poon AF
    J Virol; 2015 Oct; 89(20):10693-5. PubMed ID: 26246562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
    Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
    Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated superinfection may help HIV adaptation on rugged landscape.
    Leontiev V; Hadany L
    Infect Genet Evol; 2010 May; 10(4):505-10. PubMed ID: 20226882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis.
    Raghavan S; Selvaraj P; Swaminathan S; Alagarasu K; Narendran G; Narayanan PR
    Int J Immunogenet; 2009 Jun; 36(3):129-33. PubMed ID: 19392836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of HLA-A, B loci carrying Bw4 motif on HIV CD4 T cell count and viral load].
    Zhang X; Yan HP; Yang HB; Li WH; Zhang HP; Ji YX; Cui D
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2242-5. PubMed ID: 21029668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*5701 genetic screening prior to abacavir prescription in Georgia.
    Dvali N; Chkhartishvili N; Sharvadze L; Karchava M; Tsertsvadze T
    Georgian Med News; 2010 Dec; (189):16-20. PubMed ID: 21252404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan.
    Sun HY; Hung CC; Lin PH; Chang SF; Yang CY; Chang SY; Chang SC
    J Antimicrob Chemother; 2007 Sep; 60(3):599-604. PubMed ID: 17631508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: association of HLA-A*1101 with resistance and B*4006 with susceptibility to HIV and HIV-TB: an in silico analysis of promiscuous T cell epitopes.
    Raghavan S; Selvaraj P; Swaminathan S; Narendran G
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):1023-8. PubMed ID: 19803716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape.
    Bailey JR; Zhang H; Wegweiser BW; Yang HC; Herrera L; Ahonkhai A; Williams TM; Siliciano RF; Blankson JN
    J Infect Dis; 2007 Jul; 196(1):50-5. PubMed ID: 17538883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HLA-B allele, HLA-B*35:254, identified by sequence-based typing from a HIV-associated tuberculosis sufferer.
    Li WX; Xia JA; Yuan MX; Li G; Wang X
    HLA; 2016 Feb; 87(2):106-7. PubMed ID: 26812436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.
    Orkin C; Wang J; Bergin C; Molina JM; Lazzarin A; Cavassini M; Esser S; Gómez Sirvent JL; Pearce H
    Pharmacogenet Genomics; 2010 May; 20(5):307-14. PubMed ID: 20375757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.